NRX Pharmaceuticals Correlations

NRXP Stock

USD 2.99 0.15 4.78%

The current 90-days correlation between NRX Pharmaceuticals and Lexaria Bioscience Corp is -0.03 (i.e., Good diversification). The correlation of NRX Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

NRX Pharmaceuticals Correlation With Market

Very good diversification

The correlation between NRX Pharmaceuticals and DJI is -0.43 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NRX Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRX Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.

Moving together with NRX Stock

0.63

MLAB

Mesa Laboratories Earnings Call This Week

Pair Corr

Moving against NRX Stock

0.75	KRYS	Krystal Biotech	Pair Corr
0.66	INZY	Inozyme Pharma	Pair Corr
0.6	PDSB	PDS Biotechnology Corp	Pair Corr
0.58	MREO	Mereo BioPharma Group	Pair Corr
0.55	JNJ	Johnson Johnson	Pair Corr
0.44	NKTX	Nkarta Inc	Pair Corr
0.31	LLY	Eli Lilly Earnings Call This Week	Pair Corr
0.85	STOK	Stoke Therapeutics	Pair Corr
0.77	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.76	TERN	Terns Pharmaceuticals Buyout Trend	Pair Corr
0.71	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.7	CRVS	Corvus Pharmaceuticals	Pair Corr
0.69	PLRX	Pliant Therapeutics	Pair Corr
0.68	AFMD	Affimed NV	Pair Corr
0.66	AGIO	Agios Pharm	Pair Corr
0.64	ABOS	Acumen Pharmaceuticals	Pair Corr
0.52	BDTX	Black Diamond Therap	Pair Corr
0.43	ADAP	Adaptimmune Therapeutics	Pair Corr
0.42	AMGN	Amgen Inc Earnings Call This Week	Pair Corr
0.36	APTO	Aptose Biosciences	Pair Corr
0.66	DAWN	Day One Biopharmaceu	Pair Corr
0.58	WF	Woori Financial Group Earnings Call This Week	Pair Corr
0.54	SHG	Shinhan Financial Earnings Call This Week	Pair Corr
0.43	ACET	Adicet Bio	Pair Corr
0.4	KB	KB Financial Group Earnings Call This Week	Pair Corr
0.34	CVS	CVS Health Corp Earnings Call This Week	Pair Corr

Related Correlations Analysis

	RLFFD	PHGE	LEXX	ADTX	NTRB	QNRX	LGVN	RNXT	VRAX
RLFFD		-0.28	0.18	-0.14	-0.32	0.17	-0.22	0.28	-0.34	RLFFD
PHGE	-0.28		-0.01	0.19	0.47	0.09	0.21	-0.17	0.52	PHGE
LEXX	0.18	-0.01		0.69	-0.43	0.83	0.63	-0.45	0.0	LEXX
ADTX	-0.14	0.19	0.69		0.0	0.73	0.78	-0.8	0.01	ADTX
NTRB	-0.32	0.47	-0.43	0.0		-0.4	-0.12	-0.1	0.11	NTRB
QNRX	0.17	0.09	0.83	0.73	-0.4		0.71	-0.42	0.07	QNRX
LGVN	-0.22	0.21	0.63	0.78	-0.12	0.71		-0.62	0.1	LGVN
RNXT	0.28	-0.17	-0.45	-0.8	-0.1	-0.42	-0.62		-0.03	RNXT
VRAX	-0.34	0.52	0.0	0.01	0.11	0.07	0.1	-0.03		VRAX
	RLFFD	PHGE	LEXX	ADTX	NTRB	QNRX	LGVN	RNXT	VRAX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

QNRX	+ 0.83	LEXX
LGVN	+ 0.78	ADTX
QNRX	+ 0.73	ADTX
LGVN	+ 0.71	QNRX
ADTX	+ 0.69	LEXX
LGVN	+ 0.63	LEXX

High negative correlations

RNXT	- 0.8	ADTX
RNXT	- 0.62	LGVN
RNXT	- 0.45	LEXX
NTRB	- 0.43	LEXX
RNXT	- 0.42	QNRX
QNRX	- 0.4	NTRB

Risk-Adjusted Indicators

There is a big difference between NRX Stock performing well and NRX Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NRX Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RLFFD	1,698	915.43	142.80	(1.65)	0.00	(3,326)	7.77	(11.19)	36,552
PHGE	4.92	(0.11)	0.00	0.47	0.00	0.00	10.20	(11.29)	32.03
LEXX	3.52	(0.56)	0.00	(1.04)	0.00	0.00	7.69	(6.31)	30.19
ADTX	5.82	(2.68)	0.00	43.73	0.00	0.00	7.69	(17.39)	35.15
NTRB	5.91	0.79	0.13	1.03	5.30	(7.56)	14.32	(8.78)	54.72
QNRX	5.42	(1.26)	0.00	739.22	0.00	0.00	14.29	(9.59)	58.63
LGVN	3.02	(0.43)	0.00	(0.28)	0.00	0.00	6.70	(5.36)	17.94
RNXT	3.62	0.64	0.12	1.75	4.11	(4.30)	8.70	(6.76)	27.17
VRAX	6.32	(0.04)	0.00	0.11	0.00	0.00	19.90	(11.28)	59.66

NRX Pharmaceuticals Corporate Management

Suzanne Messere	Investor Relations	Profile
Robert MIM	Chief Operations	Profile
Michael Kunz	Gen Sec	Profile
Molly Cogan	Sr Affairs	Profile
Seth Voorhees	CFO Treasurer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC